BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7441521)

  • 1. Alterations in pentobarbital and meperidine pharmacokinetics induced by bile duct ligation in the rat.
    Knodell RG; Brooks DA; Allen RC; Kyner WT
    J Pharmacol Exp Ther; 1980 Dec; 215(3):619-25. PubMed ID: 7441521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ethinyl estradiol on pharmacokinetics of meperidine and pentobarbital in the rat.
    Knodell RG; Allen RC; Kyner WT
    J Pharmacol Exp Ther; 1982 Apr; 221(1):1-6. PubMed ID: 7062276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic uptake of foreign compounds: influence of acute extrahepatic biliary obstruction.
    Yam J; Roberts RJ
    J Pharmacol Exp Ther; 1977 Feb; 200(2):425-33. PubMed ID: 839446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
    Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
    Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of APh, gamma-GT, GlDH and GPT and bile acid concentrations in serum after bile duct obstruction and cycloheximide in the rat.
    Putzki H; Reichert B; Leemhuis B; Muckle L
    Gastroenterol J; 1991; 51(2):78-80. PubMed ID: 1684501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat. II. Pharmacokinetics and stereoselectivity of metabolism and excretion in vivo and in the perfused liver.
    te Koppele JM; Dogterom P; Vermeulen NP; Meijer DK; van der Gen A; Mulder GJ
    J Pharmacol Exp Ther; 1986 Dec; 239(3):905-14. PubMed ID: 3795049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidine dehydrogenase activity and fluorouracil pharmacokinetics with liver damage induced by bile duct ligation in rats.
    Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Sakata SF; Tamaki N; Ogura K; Nishiyama T; Watabe T; Kobayashi S
    Drug Metab Dispos; 1999 Jun; 27(6):651-4. PubMed ID: 10348793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study on rat hepatic injury by copper--effect of copper overload on the cholestatic liver induced by bile duct ligation].
    Shibuya H
    Hokkaido Igaku Zasshi; 1987 May; 62(3):434-41. PubMed ID: 3610036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis.
    Dumaswala R; Berkowitz D; Heubi JE
    Hepatology; 1996 Mar; 23(3):623-9. PubMed ID: 8617445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bile duct obstruction on hepatic uptake of 1-methyl-4-phenylpyridinium in the rat.
    Martel F; Calhau C; Hipólito-Reis C
    Pharmacol Res; 1998 Jun; 37(6):497-504. PubMed ID: 9695124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liver congestion on hepatic drug metabolism in the rat.
    Knodell RG; Farleigh RM; Steele NM; Bond JH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of extrahepatic cholestasis on metabolism and biliary excretion of imipramine.
    Gigon PL
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):211-21. PubMed ID: 1147718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of hepatic blood flow and intrahepatic microvascular bed in rats with chronic biliary obstruction].
    Chen XS
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):751-4, 780. PubMed ID: 1339754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of etoposide in isolated, perfused rat liver models.
    Hande K; Bennett R; Hamilton R; Grote T; Branch R
    Cancer Res; 1988 Oct; 48(20):5692-5. PubMed ID: 3167829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bile duct ligation on calcium excretion in the rat.
    Vakil N; Sharma A; Yagil Y
    Hepatology; 1994 Feb; 19(2):457-63. PubMed ID: 8294102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas.
    Chang RL; Zampaglione N; Lin C
    Drug Metab Dispos; 1975; 3(6):487-93. PubMed ID: 1223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of digoxin in the rat.
    Harrison LI; Gibaldi M
    Drug Metab Dispos; 1976; 4(1):88-93. PubMed ID: 3407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and characterization of hepatocytes from chronic cholestatic damage to rat livers after bile duct ligation].
    Hinz S; Müller A; Machnik G; Franke H; Zimmermann T; Dargel R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():24-7. PubMed ID: 7483707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.